Strategy
Eight Steps to Successful Oncology Drug Development
Some biopharma companies are beginning to question whether oncology is still an attractive therapeutic area in which to invest. The simple answer to this, write Matthew Cook and Sebastien Morisot, is yes. Here the authors provide eight key ingredients for a successful oncology drug development recipe ...Read more

R&D
Pharma Under Attack for Failing to Develop New Antibiotics
The pharma industry is under attack for failing to develop new antibiotics to treat emerging infections. Dire warnings from the World Health Organization and others have prompted calls for new innovation models that would provide alternatives to the patent-based intellectual property system ...Read more

This white paper examines the current state of risk-based monitoring and builds on the extensive work done by TransCelerate BioPharma as well as regulatory authorities worldwide. It reviews the limitations of current eClinical technology to support the monitoring best practices called for, and why sponsors and CROs are shifting to comprehensive, real-time analytics as the technology backbone to effectively conduct a strategic risk-based monitoring program.Read more

Emerging Markets
Gravity Shift: What Can Multinationals Learn from Generic Companies?
Asia could well become the biggest pharmaceutical market and will look radically different in the medium-term. In the last three decades, MNCs have contributed greatly to the transfer of knowledge to generic companies in the region. But now its time for MNCs to learn from the generics, writes Nadeem Rehmat ...Read more

Rymax Marketing Services is a one-stop shop for medical meetings and event planners offering unique experiences and services. We create sales incentive and loyalty programs designed to increase employee and customer retention. With 300 aspirational, high equity brands and exclusive rewards to compliment signature events, we ship directly from our nationwide warehouses to help drive our clients’ ROI and revenue.www.rymaxinc.com/customer-loyalty.aspx

Regulatory
FDA, Drug Companies Struggle with Compassionate Use Requests
When a 7-year-old cancer patient gained relief from a life-threatening infection following a bone marrow transplant thanks to Chimerix’s antiviral drug brincidofovir, hundreds of patients called for similar compassionate access. The trend demonstrates the need for sponsors, health professionals and regulators to find new ways to handle these difficult requests, while supporting clinical research and biomedical R&D ...Read more

Adam Smith Conferences’ Russian Pharmaceutical Forum

Fresh and innovative programme offers plenty of topics and themes to stimulate lively and constructive discussions. HEARover 100 expert speakers (Novartis, AstraZeneca, Pfizer, Teva, Stada, Takeda, Dr.Reddys), EXPERIENCE sessions sharing the best pharmaceutical practices (Generics vs Brands, Biogeneric Producers vs Biological Innovators, Patient Advocacy), LISTEN to special guest addresses (Multichannel Marketing Strategy) and GATHER inspirational ideas from executive debates (Distribution Strategy).

Date: June 17 - 19, 2014
Location: St.Petersburg, Russia
Venue: Corinthia St.Petersburg Hotel
Contact: Lyudmyla Durneva +44 (0) 207 551 9065 Lyudmyla@adamsmithconferences.com
Website:www.adamsmithconferences.com/as2279PHEX

Special Feature
Pharm Exec’s Brand of the Year
Pharm Exec's Brand of the Year recipients for 2014 are a mainstay treatment for multiple sclerosis, and — lest we be accused of being safely predictable — we also focus on clinical and marketing achievement for an orphan-status rare disease drug ...Read more

How Digital Medicine Can Pinpoint Dosing Regimens to Optimize Drug Efficacy and Safety
On Demand Webcast
To Register free: www.pharmexec.com/pinpoint

Pharm Exec's Brands of Yesteryear: Where Are They Now?

Merger Mania: When the Music Stops

Middle East Meltdown: Diabetes in the Arab Context